×

2 common MS treatments show equal benefit in late-onset disease

2 common MS treatments show equal benefit in late-onset disease

Comments Off on 2 common MS treatments show equal benefit in late-onset disease

A photo shows a balance scale.

Two commonly used disease-modifying treatments seem to be equally effective for most people with late-onset multiple sclerosis (LOMS), according to a real-world analysis. Anti-CD20 therapies, designed to reduce immune cells that produce disease-driving antibodies, and S1P receptor modulators, which work by preventing pro-inflammatory immune cells from reaching the brain, showed similar benefits across measures of disease […]

The post 2 common MS treatments show equal benefit in late-onset disease appeared first on Multiple Sclerosis News Today.

Source: multiplesclerosisnewstoday.com